Industry-leading image quality at a fraction of the dose
In the dynamic field of minimally invasive therapy, exceptional drive and dedication is required to perform an increasing number of complex procedures. Accurate visualisations and real-time navigation are crucial, whether delicately maneuvering through tortuous vasculature or racing to remove a blood clot.
During interventions you can’t afford to make a trade-off between image quality and X-ray dose. But what if you could reduce X-ray dose by 73 percent for neuro-radiology interventions without affecting image quality and your way of working? Now you can with Philips revolutionary new generation of interventional X-ray systems: the Allura Clarity family.
Philips’ unique ClarityIQ technology makes this quantum leap in X-ray dose reduction possible. It dramatically reduces X-ray dose by 73 percent while delivering equivalent image quality. ClarityIQ technology pushes the boundaries of the As Low as Reasonably Achievable (ALARA) principle to improve interventional medicine. Patient and staff risks from exposure to radiation are radically reduced. Longer and more complex procedures can now be performed more safely.
Reduced X-ray dose leads to fewer patient complications from radiation exposure. Decreased scatter radiation reduces long-term health risks for staff. Lower X-ray dose enables longer procedures to treat obese and high-risk patients.
“We were willing to accept that the image quality would decrease because we thought 73 percent X-ray dose reduction was so significant. But it turned out that image quality actually improved”
Dr M Söderman, Stockholm, Sweden (interventional Neuroradiology)
• Improves patient safety – dramatically reduces X-ray dose for fewer complications from radiation exposure.
• Improves physician and staff safety – decreases scatter radiation, thereby reducing long-term health risks.
• Expands treatment options – enables longer procedures to treat obese
and high-risk patients more safely.
The advancements in technology will not only significantly help improve diagnostic effectiveness, but will also ensure that patients and hospital staff
will experience fewer complications from radiation exposure.
With AlluraClarity, the initial clinical trials have shown an average reduction of 50 percent radiation dose without sacrificing image quality in coronary angiography. Studies in other types of applications, such as DSA angiography, have shown even further dose reduction of up to 83 percent